Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 25, 2024
ER-phagy
is
a
double-edged
sword
in
the
occurrence,
development,
and
treatment
of
cancer;
especially,
its
functions
immunotherapy
are
still
unknown.
In
this
work,
we
designed
theranostic
Re
complex
(
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
The
infiltration
and
excessive
polarization
of
M1
macrophages
contribute
to
the
induction
persistence
low‐grade
inflammation
in
joint‐related
degenerative
diseases
such
as
osteoarthritis
(OA).
lipid
metabolism
dysregulation
promotes
macrophage
by
coordinating
compensatory
pathways
inflammatory
oxidative
stress
responses.
Here,
a
self‐assembling,
licofelone‐loaded
nanoparticle
(termed
LCF‐CSBN),
comprising
chondroitin
sulfate
bilirubin
joined
an
ethylenediamine
linker,
is
developed
selectively
reprogram
activation.
LCF‐CSBN
internalized
via
CD44‐mediated
endocytosis
targets
Golgi
apparatus
accompanied
with
reactive
oxygen
species‐responsive
release
licofelone
(LCF,
dual
inhibitor
arachidonic
acid
metabolism).
effectively
M2
transition
reprogramming
apparatus‐related
sphingolipid
metabolism.
Intra‐articularly
injected
retains
joint
for
up
28
days
accumulates
into
macrophages.
Moreover,
can
attenuate
inflammation,
stress,
cartilage
degeneration
OA
model
rats.
These
findings
indicate
promising
potential
lipid‐metabolism‐reprogramming
targeted
therapy
OA.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(17)
Published: March 14, 2024
The
Golgi
apparatus
(GA)
is
central
in
shuttling
proteins
from
the
endoplasmic
reticulum
to
different
cellular
areas.
Therefore,
targeting
GA
precisely
destroy
its
through
local
heat
could
induce
apoptosis,
offering
a
potential
avenue
for
effective
cancer
therapy.
Herein,
GA-targeted
photothermal
agent
based
on
protein
anchoring
introduced
enhanced
therapy
of
tumor
modification
near-infrared
molecular
dye
with
maleimide
derivative
and
benzene
sulfonamide.
can
actively
target
covalently
anchor
sulfhydryl
proteins,
thereby
increasing
retention
within
GA.
Under
laser
irradiation,
generated
by
efficiently
disrupts
situ,
leading
dysfunction
ultimately
inducing
cell
apoptosis.
In
vivo
experiments
demonstrate
that
treat
tumors
significantly
reduce
side
effects.
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
67(10), P. 8020 - 8042
Published: May 10, 2024
Promising
targeted
therapy
options
to
overcome
drug
resistance
and
side
effects
caused
by
platinum(II)
drugs
for
treatment
in
hepatocellular
carcinoma
are
urgently
needed.
Herein,
six
novel
multifunctional
platinum(IV)
complexes
through
linking
agents
glycyrrhetinic
acid
(GA)
were
designed
synthesized.
Among
them,
complex
20
showed
superior
antitumor
activity
against
tested
cancer
cells
including
cisplatin
than
simultaneously
displayed
good
liver-targeting
ability.
Moreover,
can
significantly
cause
DNA
damage
mitochondrial
dysfunction,
promote
reactive
oxygen
species
generation,
activate
endoplasmic
reticulum
stress,
eventually
induce
apoptosis.
Additionally,
effectively
inhibit
cell
migration
invasion
trigger
autophagy
ferroptosis
HepG-2
cells.
More
importantly,
demonstrated
stronger
tumor
inhibition
ability
or
the
combo
of
cisplatin/GA
with
almost
no
systemic
toxicity
A549
xenograft
models.
Collectively,
could
be
developed
as
a
potential
anti-HCC
agent
treatment.
Aggregate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 22, 2024
ABSTRACT
Long‐term
in
vivo
fluorescence
analysis
is
growing
into
a
sparkling
frontier
gaining
deep
insights
various
biological
processes.
Exploration
of
such
fluorophores
with
high
performance
still
remains
an
appealing
yet
significantly
challenging
task.
In
this
study,
we
have
elaborately
integrated
second
near‐infrared
(NIR‐II)
emissive
fluorophore
the
metal
Pt
self‐assembled
prism‐like
metallacage
M‐DBTP,
which
enables
intravital
long‐term
tracking
through
NIR‐II
imaging
technologies.
addition,
bioimaging
metallacage‐loaded
nanoparticles
(NPs)
indicated
extraordinary
photographic
on
mice
blood
vessels
and
rapid
clearance
M‐DBTP
NPs
from
within
7
h.
The
subsequent
transfer
to
bones
retention
bone
marrow
region
for
up
35
days
was
revealed
by
analysis,
confirmed
distribution
metabolism
inductively
coupled
plasma
optical
emission
spectrometer.
Moreover,
bright
them
well
perform
imaging‐guided
tumor
surgery.
Biology,
Journal Year:
2023,
Volume and Issue:
13(1), P. 1 - 1
Published: Dec. 19, 2023
Although
the
discovery
of
Golgi
apparatus
(GA)
was
made
over
125
years
ago,
only
a
very
limited
number
therapeutic
approaches
have
been
developed
to
target
this
complex
organelle.
The
GA
serves
as
modification
and
transport
center
for
proteins
lipids
also
has
more
recently
emerged
an
important
store
some
ions.
dysregulation
functions
is
implicated
in
many
cellular
processes
associated
with
cancer
are
indeed
described
biomarkers.
This
can
affect
protein
modification,
localization,
secretion,
but
metabolism,
redox
status,
extracellular
pH,
matrix
structure.
Consequently,
it
directly
or
indirectly
progression.
For
these
reasons,
appealing
anticancer
pharmacological
target.
Despite
this,
no
drug
specifically
targeting
reached
clinic
few
entered
clinical
trial
stage.
Advances
nanodelivery
may
help
change
scenario
by
tumor
cells
and/or
through
passive,
active,
physical
strategies.
article
aims
examine
currently
available
GA-targeted
drugs
strategies
explored
their
administration.
potential
benefits
challenges
modulating
function
context
therapy
discussed.
Cell & Bioscience,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 22, 2024
Abstract
The
Golgi
apparatus
is
the
central
hub
of
cellular
endocrine
pathway
and
plays
a
crucial
role
in
processing,
transporting,
sorting
proteins
lipids.
Simultaneously,
it
highly
dynamic
organelle
susceptible
to
degradation
or
fragmentation
under
various
physiological
pathological
conditions,
potentially
contributing
development
numerous
human
diseases.
Autophagy
serves
as
vital
for
eukaryotes
manage
intracellular
extracellular
stress
maintain
homeostasis
by
targeting
damaged
redundant
organelles
removal.
Recent
research
has
revealed
that
autophagy
mechanisms
can
specifically
degrade
components,
known
Golgiphagy.
This
review
summarizes
recent
findings
on
Golgiphagy
while
also
addressing
unanswered
questions
regarding
its
regulation,
aiming
advance
our
understanding
disease.
Engineered Regeneration,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 1, 2024
Golgi
apparatus
(GA)
is
an
organelle
widely
present
in
eukaryotic
cells
and
involved
a
variety
of
cellular
physiological
activities,
including
but
not
limited
to
protein
modification
secretion.
There
increasing
evidence
that
structural
or
functional
disorders
the
GA
are
closely
associated
with
occurrence
development
diseases.
As
potential
therapeutic
targets,
researchers
have
developed
GA-targeted
drug
delivery
systems
(DDS)
for
disease
treatment.
Compared
traditional
therapy,
DDS
achieves
remarkable
curative
effect
high
specificity,
low
dose,
reduced
resistance
side
effects,
via
alterations
morphology
biosynthesis.
Therefore,
therapy
great
clinical
significance
has
broad
application
prospects.
In
this
review,
structure
function
briefly
introduced,
mechanisms
entering
binding
classified.
Then
typical
applications
diagnosis
treatment
cancer,
cardiovascular
diseases,
fibrosis,
infectious
diseases
neurodegenerative
introduced
detail,
displaying
its
At
last,
bottlenecks
future
field
discussed.
It
our
hope
review
will
inspire
GA-based
foreseeable
future.